In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

Background Among low-risk patients with severe, symptomatic aortic stenosis who are
eligible for both transcatheter aortic-valve implantation (TAVI) and surgical aortic-valve …

Transcatheter technologies triggered the recent revision of the guidelines that progressively
widened the indications for the treatment of aortic stenosis. On the surgical realm, a …

Abstract Background and Aims Transcatheter aortic valve implantation (TAVI) has become a
viable treatment option for patients with severe aortic valve stenosis across a broad range of …

Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …

Transcatheter aortic valve implantation (TAVI) is now utilised as a less invasive alternative to
surgical aortic valve replacement (SAVR) across the whole spectrum of surgical risk. Long …

Background Consensus guidelines recommend surgical aortic valve replacement (SAVR)
over transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis …

Importance Transcatheter aortic valve replacement (TAVR) is an established treatment
option for many patients with severe symptomatic aortic stenosis; however, debris dislodged …

Abstract Background and Aims Transcatheter aortic valve implantation (TAVI) has become
the first choice to treat older patients with severe symptomatic aortic stenosis (AS). This study …

Transcatheter aortic valve (TAV) thrombosis may manifest as subclinical leaflet thrombosis
(SLT) and clinical valve thrombosis. SLT is relatively common (10%-20%) after transcatheter …